Ballentine Partners, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$244,820
-43.8%
6,487
-32.1%
0.01%
-40.0%
Q2 2023$435,326
+48.8%
9,555
+32.5%
0.01%
+42.9%
Q1 2023$292,479
+9.1%
7,211
+37.1%
0.01%
-12.5%
Q4 2022$268,153
-23.4%
5,261
-19.1%
0.01%
-33.3%
Q3 2022$350,000
-2.5%
6,501
+16.5%
0.01%
-7.7%
Q2 2022$359,000
-21.8%
5,582
-5.6%
0.01%
-7.1%
Q1 2022$459,000
-8.6%
5,914
+1.1%
0.01%
-6.7%
Q4 2021$502,000
+8.7%
5,848
+1.9%
0.02%
-6.2%
Q3 2021$462,000
-1.3%
5,738
-1.3%
0.02%0.0%
Q2 2021$468,000
-2.5%
5,813
+2.2%
0.02%
-11.1%
Q1 2021$480,000
-7.7%
5,686
-12.2%
0.02%
-14.3%
Q4 2020$520,000
-10.8%
6,473
-10.8%
0.02%
-19.2%
Q3 2020$583,000
-11.3%
7,255
-4.9%
0.03%
-16.1%
Q2 2020$657,000
+6.3%
7,629
+0.3%
0.03%
-13.9%
Q1 2020$618,000
+4.2%
7,603
+7.2%
0.04%
+33.3%
Q4 2019$593,000
-5.1%
7,094
-0.7%
0.03%
-6.9%
Q3 2019$625,000
+10.6%
7,147
+3.5%
0.03%
+7.4%
Q2 2019$565,000
+8.9%
6,905
+8.2%
0.03%0.0%
Q1 2019$519,000
+21.0%
6,381
-2.2%
0.03%
+8.0%
Q4 2018$429,000
-19.5%
6,526
-5.6%
0.02%
-10.7%
Q3 2018$533,000
+2.5%
6,914
-1.8%
0.03%
-3.4%
Q2 2018$520,000
+136.4%
7,044
+107.8%
0.03%
+141.7%
Q1 2018$220,000
-10.2%
3,390
-10.5%
0.01%
-7.7%
Q4 2017$245,000
+3.8%
3,789
+0.3%
0.01%0.0%
Q3 2017$236,000
-14.8%
3,777
-15.9%
0.01%
-35.0%
Q2 2017$277,0004,4930.02%
Other shareholders
BAXTER INTL INC shareholders Q1 2023
NameSharesValueWeighting ↓
GENERATION INVESTMENT MANAGEMENT LLP 21,171,371$1,817,350,0007.47%
Soditic Asset Management LLP 147,620$12,672,0006.53%
NUANCE INVESTMENTS, LLC 4,084,218$350,589,0006.17%
PRAGMA GESTAO DE PATRIMONIO LTD 145,000$12,4475.96%
Veritas Asset Management LLP 12,222,261$1,049,159,0005.89%
Pavadi Capital LLC 72,782$6,248,0004.74%
Sonen Capital LLC 48,907$4,198,0004.06%
Glenview Capital Management 2,182,422$187,339,0003.99%
Dash Acquisitions Inc. 103,963$8,924,0003.87%
Avidity Partners Management LP 1,765,000$151,508,0003.21%
View complete list of BAXTER INTL INC shareholders